Prognostic or predictive plasma cytokines and angiogenic factors for patients treated with pazopanib for metastatic renal-cell cancer: a retrospective analysis of phase 2 and phase 3 trials (Q44272543)

From Wikidata

Jump to navigation Jump to search

scientific article

Language	Label	Description	Also known as
English	Prognostic or predictive plasma cytokines and angiogenic factors for patients treated with pazopanib for metastatic renal-cell cancer: a retrospective analysis of phase 2 and phase 3 trials	scientific article

Statements

scholarly article

1 reference

Europe PubMed Central

PubMed publication ID

1 December 2017

Prognostic or predictive plasma cytokines and angiogenic factors for patients treated with pazopanib for metastatic renal-cell cancer: a retrospective analysis of phase 2 and phase 3 trials (English)

1 reference

Europe PubMed Central

PubMed publication ID

1 December 2017

phase III clinical trial

0 references

phase II clinical trial

0 references

0 references

1 reference

ChEBI release 2020-05-28

12

object named as

John V Heymach

1 reference

Europe PubMed Central

PubMed publication ID

1 December 2017

9

object named as

Cora N Sternberg

1 reference

Europe PubMed Central

PubMed publication ID

1 December 2017

author name string

Hai T Tran

1

1 reference

Europe PubMed Central

PubMed publication ID

1 December 2017

Yuan Liu

2

1 reference

Europe PubMed Central

PubMed publication ID

1 December 2017

Amado J Zurita

3

1 reference

Europe PubMed Central

PubMed publication ID

1 December 2017

Ying Lin

4

1 reference

Europe PubMed Central

PubMed publication ID

1 December 2017

Katherine L Baker-Neblett

5

1 reference

Europe PubMed Central

PubMed publication ID

1 December 2017

Anne-Marie Martin

6

1 reference

Europe PubMed Central

PubMed publication ID

1 December 2017

Robert A Figlin

7

1 reference

Europe PubMed Central

PubMed publication ID

1 December 2017

Thomas E Hutson

8

1 reference

Europe PubMed Central

PubMed publication ID

1 December 2017

Rafael G Amado

10

1 reference

Europe PubMed Central

PubMed publication ID

1 December 2017

Lini N Pandite

11

1 reference

Europe PubMed Central

PubMed publication ID

1 December 2017

publication date

2 July 2012

1 reference

Europe PubMed Central

PubMed publication ID

1 December 2017

Lancet Oncology Commission

1 reference

Europe PubMed Central

PubMed publication ID

1 December 2017

13

1 reference

Europe PubMed Central

PubMed publication ID

1 December 2017

8

1 reference

Europe PubMed Central

PubMed publication ID

1 December 2017

827-837

1 reference

Europe PubMed Central

PubMed publication ID

1 December 2017

Mutations of the VHL tumour suppressor gene in renal carcinoma

1 reference

https://api.crossref.org/works/10.1016%2FS1470-2045%2812%2970241-3

7 January 2021

based on heuristic

inferred from DOI database lookup

Overproduction of vascular endothelial growth factor related to von Hippel-Lindau tumor suppressor gene mutations and hypoxia-inducible factor-1 alpha expression in renal cell carcinomas.

1 reference

https://api.crossref.org/works/10.1016%2FS1470-2045%2812%2970241-3

7 January 2021

based on heuristic

inferred from DOI database lookup

Targeting HIF-1 for cancer therapy

1 reference

https://api.crossref.org/works/10.1016%2FS1470-2045%2812%2970241-3

7 January 2021

based on heuristic

inferred from DOI database lookup

Expression of vascular endothelial growth factor protein in human renal cell carcinoma

1 reference

https://api.crossref.org/works/10.1016%2FS1470-2045%2812%2970241-3

7 January 2021

based on heuristic

inferred from DOI database lookup

Sunitinib versus interferon alfa in metastatic renal-cell carcinoma

1 reference

https://api.crossref.org/works/10.1016%2FS1470-2045%2812%2970241-3

7 January 2021

based on heuristic

inferred from DOI database lookup

Efficacy and safety of pazopanib in patients with metastatic renal cell carcinoma

1 reference

https://api.crossref.org/works/10.1016%2FS1470-2045%2812%2970241-3

7 January 2021

based on heuristic

inferred from DOI database lookup

Sorafenib in advanced clear-cell renal-cell carcinoma

1 reference

https://api.crossref.org/works/10.1016%2FS1470-2045%2812%2970241-3

7 January 2021

based on heuristic

inferred from DOI database lookup

Bevacizumab plus interferon alfa-2a for treatment of metastatic renal cell carcinoma: a randomised, double-blind phase III trial

1 reference

https://api.crossref.org/works/10.1016%2FS1470-2045%2812%2970241-3

7 January 2021

based on heuristic

inferred from DOI database lookup

Pazopanib in locally advanced or metastatic renal cell carcinoma: results of a randomized phase III trial

1 reference

https://api.crossref.org/works/10.1016%2FS1470-2045%2812%2970241-3

7 January 2021

based on heuristic

inferred from DOI database lookup

Circulating biomarkers for vascular endothelial growth factor inhibitors in renal cell carcinoma

1 reference

https://api.crossref.org/works/10.1016%2FS1470-2045%2812%2970241-3

7 January 2021

based on heuristic

inferred from DOI database lookup

Incidence of brain metastases in renal cell carcinoma treated with sorafenib

1 reference

https://api.crossref.org/works/10.1016%2FS1470-2045%2812%2970241-3

7 January 2021

based on heuristic

inferred from DOI database lookup

Efficacy and safety of sorafenib in patients with advanced renal cell carcinoma with and without prior cytokine therapy, a subanalysis of TARGET.

1 reference

https://api.crossref.org/works/10.1016%2FS1470-2045%2812%2970241-3

7 January 2021

based on heuristic

inferred from DOI database lookup

Pazopanib efficacy in renal cell carcinoma: evidence for predictive genetic markers in angiogenesis-related and exposure-related genes.

1 reference

https://api.crossref.org/works/10.1016%2FS1470-2045%2812%2970241-3

7 January 2021

based on heuristic

inferred from DOI database lookup

Plasma cytokine and angiogenic factor profiling identifies markers associated with tumor shrinkage in early-stage non-small cell lung cancer patients treated with pazopanib

1 reference

https://api.crossref.org/works/10.1016%2FS1470-2045%2812%2970241-3

7 January 2021

based on heuristic

inferred from DOI database lookup

Distinct patterns of cytokine and angiogenic factor modulation and markers of benefit for vandetanib and/or chemotherapy in patients with non-small-cell lung cancer.

1 reference

https://api.crossref.org/works/10.1016%2FS1470-2045%2812%2970241-3

7 January 2021

based on heuristic

inferred from DOI database lookup

Phase II trial of infusional fluorouracil, irinotecan, and bevacizumab for metastatic colorectal cancer: efficacy and circulating angiogenic biomarkers associated with therapeutic resistance

1 reference

https://api.crossref.org/works/10.1016%2FS1470-2045%2812%2970241-3

7 January 2021

based on heuristic

inferred from DOI database lookup

A cytokine and angiogenic factor (CAF) analysis in plasma for selection of sorafenib therapy in patients with metastatic renal cell carcinoma

1 reference

https://api.crossref.org/works/10.1016%2FS1470-2045%2812%2970241-3

7 January 2021

based on heuristic

inferred from DOI database lookup

Altered chemokine profile associated with exacerbated autoimmune pathology under conditions of genetic interferon-gamma deficiency

1 reference

https://api.crossref.org/works/10.1016%2FS1470-2045%2812%2970241-3

7 January 2021

based on heuristic

inferred from DOI database lookup

Cell adhesion molecules, vascular endothelial growth factor, and basic fibroblast growth factor in patients with non-small cell lung cancer treated with chemotherapy with or without bevacizumab--an Eastern Cooperative Oncology Group Study

1 reference

https://api.crossref.org/works/10.1016%2FS1470-2045%2812%2970241-3

7 January 2021

based on heuristic

inferred from DOI database lookup

VEGF as a marker for outcome among advanced breast cancer patients receiving anti-VEGF therapy with bevacizumab and vinorelbine chemotherapy

1 reference

https://api.crossref.org/works/10.1016%2FS1470-2045%2812%2970241-3

7 January 2021

based on heuristic

inferred from DOI database lookup

More powerful procedures for multiple significance testing

1 reference

https://api.crossref.org/works/10.1016%2FS1470-2045%2812%2970241-3

7 January 2021

based on heuristic

inferred from DOI database lookup

Interferon-alfa as a comparative treatment for clinical trials of new therapies against advanced renal cell carcinoma

1 reference

https://api.crossref.org/works/10.1016%2FS1470-2045%2812%2970241-3

7 January 2021

based on heuristic

inferred from DOI database lookup

Prognostic factors for overall survival in patients with metastatic renal cell carcinoma treated with vascular endothelial growth factor-targeted agents: results from a large, multicenter study

1 reference

https://api.crossref.org/works/10.1016%2FS1470-2045%2812%2970241-3

7 January 2021

based on heuristic

inferred from DOI database lookup

Biomarkers predicting outcome in patients with advanced renal cell carcinoma: Results from sorafenib phase III Treatment Approaches in Renal Cancer Global Evaluation Trial

1 reference

https://api.crossref.org/works/10.1016%2FS1470-2045%2812%2970241-3

7 January 2021

based on heuristic

inferred from DOI database lookup

HER2/neu role in breast cancer: from a prognostic foe to a predictive friend

1 reference

https://api.crossref.org/works/10.1016%2FS1470-2045%2812%2970241-3

7 January 2021

based on heuristic

inferred from DOI database lookup

HER2 evaluation and its impact on breast cancer treatment decisions

1 reference

https://api.crossref.org/works/10.1016%2FS1470-2045%2812%2970241-3

7 January 2021

based on heuristic

inferred from DOI database lookup

Cytokines and angiogenic factors in patients with metastatic renal cell carcinoma treated with interferon-alpha: association of pretreatment serum levels with survival

1 reference

https://api.crossref.org/works/10.1016%2FS1470-2045%2812%2970241-3

7 January 2021

based on heuristic

inferred from DOI database lookup

Basal cytokines profile in metastatic renal cell carcinoma patients treated with subcutaneous IL-2-based therapy compared with that of healthy donors

1 reference

https://api.crossref.org/works/10.1016%2FS1470-2045%2812%2970241-3

7 January 2021

based on heuristic

inferred from DOI database lookup

Interleukin-6, interleukin-10, and vascular endothelial growth factor in metastatic renal cell carcinoma: prognostic value of interleukin-6--from the Groupe Francais d'Immunotherapie

1 reference

https://api.crossref.org/works/10.1016%2FS1470-2045%2812%2970241-3

7 January 2021

based on heuristic

inferred from DOI database lookup

Sorafenib for treatment of renal cell carcinoma: Final efficacy and safety results of the phase III treatment approaches in renal cancer global evaluation trial.

1 reference

https://api.crossref.org/works/10.1016%2FS1470-2045%2812%2970241-3

7 January 2021

based on heuristic

inferred from DOI database lookup

Effect of low-fat diets on plasma levels of NF-κB-regulated inflammatory cytokines and angiogenic factors in men with prostate cancer.

1 reference

https://api.crossref.org/works/10.1016%2FS1470-2045%2812%2970241-3

7 January 2021

based on heuristic

inferred from DOI database lookup

Identifiers

10.1016/S1470-2045(12)70241-3

1 reference

Europe PubMed Central

PubMed publication ID

1 December 2017

PubMed publication ID

1 reference

Europe PubMed Central

PubMed publication ID

1 December 2017

Sitelinks

Wikipedia(0 entries)

Wikibooks(0 entries)

Wikinews(0 entries)

Wikiquote(0 entries)

Wikisource(0 entries)

Wikiversity(0 entries)

Wikivoyage(0 entries)

Wiktionary(0 entries)

Multilingual sites(0 entries)

Retrieved from "https://www.wikidata.org/w/index.php?title=Q44272543&oldid=2186353194"